Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-29 @ 12:33 PM
Study NCT ID:
NCT03475004
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2018-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer
Sponsor:
University of Colorado, Denver
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
17-0466.cc
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None